Cargando…
Impact of Nuclear Medicine and Radiopharmaceuticals on Health-care Delivery: Advances, Lessons, and Need for an Objective Value-matrix
The nuclear medicine (NM) growth has gone through both evolutionary and revolutionary changes over decades, mostly attributable to the dynamic and responsive trends in the global development and deployment of radiopharmaceuticals (RPh), as well as the advent of superior technology imaging systems (s...
Autor principal: | Ramamoorthy, Natesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194776/ https://www.ncbi.nlm.nih.gov/pubmed/30386046 http://dx.doi.org/10.4103/ijnm.IJNM_56_18 |
Ejemplares similares
-
Editorial: Reviews in: Radiopharmaceuticals in nuclear medicine
por: Lau, Chuen-Yen, et al.
Publicado: (2023) -
Compelling Case for Fostering Titanium-45 for Positron Emission Tomography Tracer Applications
por: Ramamoorthy, Natesan
Publicado: (2020) -
Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014) -
Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
por: Meher, Bikash Ranjan
Publicado: (2020) -
Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
por: Pisaneschi, Federica, et al.
Publicado: (2021)